[VRDN] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
20-Apr-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -109.18%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 1,050 4,461 8,386 4,003 3,337 2,538 4,320 -20.98%
PBT -110,715 -41,873 -32,703 -26,512 -12,674 -11,328 -7,890 55.24%
Tax 269 547 1,254 95 95 0 1,023 -19.94%
NP -110,984 -42,420 -32,703 -26,512 -12,674 -11,328 -7,890 55.30%
Tax Rate - - - - - - - -
Total Cost 112,034 46,881 41,089 30,515 16,011 13,866 12,210 44.64%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -10,569.90 -950.91 -389.97 -662.30 -379.80 -446.34 -182.64 96.55%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -31.20 -20.31 -16.57 -20.66 -17.57 -21.00 -52.46 -8.28%
EPS Diluted -31.20 -20.31 -16.57 -20.66 -17.57 -21.00 -52.46 -8.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.